Search

everythinglearnresearchcommunity

for

Search:↓

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

Elf5 controls skin cell growth and development, making it a potential target for skin treatments.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Targeting regulatory T cells may help treat age-related diseases.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

QLT0267 stops hair follicle cell growth and movement.

The lemur's testicular tumor was removed, improving its coat and behavior, with no signs of cancer spread.

The study found that tight junctions reach the top layer of the skin's stratum granulosum, not just the second top layer as previously thought.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

High TSPEAR levels in colorectal cancer predict worse outcomes.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Normal skin results from interactions between EGF and the Tabby mutation.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.